GT
BSX icon

Glenview Trust’s Boston Scientific BSX Stock Holding History

Glenview Trust’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Buy
254,089
+32,757
+15% +$1.78M 0.15% 116
2026
Q1 		$13.9M Buy
221,332
+191,081
+632% +$15.3M 0.22% 91
2025
Q4 		$2.88M Sell
30,251
-421
-1% -$41.3K 0.04% 198
2025
Q3 		$2.99M Buy
30,672
+291
+1% +$30.1K 0.05% 196
2025
Q2 		$3.26M Buy
30,381
+28
+0.1% +$2.83K 0.06% 184
2025
Q1 		$3.06M Buy
30,353
+269
+0.9% +$27.1K 0.06% 177
2024
Q4 		$2.69M Sell
30,084
-1,001
-3% -$88.1K 0.05% 186
2024
Q3 		$2.6M Sell
31,085
-107
-0.3% -$8.44K 0.05% 188
2024
Q2 		$2.4M Buy
31,192
+1,541
+5% +$113K 0.05% 185
2024
Q1 		$2.03M Buy
29,651
+38
+0.1% +$2.44K 0.04% 202
2023
Q4 		$1.71M Buy
29,613
+127
+0.4% +$6.78K 0.04% 206
2023
Q3 		$1.56M Buy
29,486
+54
+0.2% +$2.83K 0.04% 197
2023
Q2 		$1.59M Sell
29,432
-1,438
-5% -$75.1K 0.04% 186
2023
Q1 		$1.54M Buy
30,870
+39
+0.1% +$1.84K 0.05% 186
2022
Q4 		$1.43M Buy
30,831
+9,987
+48% +$432K 0.05% 190
2022
Q3 		$807K Buy
20,844
+7,846
+60% +$315K 0.03% 219
2022
Q2 		$484K Buy
12,998
+65
+0.5% +$2.65K 0.02% 284
2022
Q1 		$573K Buy
+12,933
New +$560K 0.02% 276
2021
Q4 		– Sell
-4,680
Closed -$203K – 419
2021
Q3 		$203K Hold
4,680
– – 0.01% 395
2021
Q2 		$200K Buy
+4,680
New +$197K 0.01% 403
2014
Q4 		$195K Buy
+14,697
New +$188K 0.02% 224

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Glenview Trust's BSX Position: Q2 2026 in Review

Glenview Trust increased its Boston Scientific (BSX) stake by 15% in Q2 2026, buying an estimated $1.78M and bringing the position to 254,089 shares worth $10.8M. The position accounts for 0.15% of the portfolio, ranked #116.

Glenview Trust first reported a position in BSX in Q4 2014 and has held it in 21 quarters since. The position peaked at $13.9M in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Glenview Trust held 254,089 shares of Boston Scientific worth $10.8M as of Q2 2026.
  • Glenview Trust bought 32,757 Boston Scientific shares in Q2 2026, an estimated $1.78M.
  • Boston Scientific made up 0.15% of Glenview Trust's portfolio in Q2 2026, its #116 holding.
  • Glenview Trust first reported a position in Boston Scientific in Q4 2014 and has held it in 21 quarters since.
  • Glenview Trust's Boston Scientific position peaked at $13.9M in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.